单于黎云
Lv41
530 积分
2022-01-05 加入
-
Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report
2个月前
已完结
-
Efficacy and effectiveness of omalizumab in the treatment of childhood asthma
5个月前
已完结
-
Bactericidal ability of target acidic phospholipids and phagocytosis of CDC42 GTPase-mediated cytoskeletal rearrangement underlie functional conservation of CXCL12 in vertebrates
8个月前
已完结
-
Cdc42 promotes thyroid cancer cell proliferation and migration and tumor‐associated macrophage polarization through the PTEN/AKT pathway
8个月前
已完结
-
Anti-IL-4/IL-13 for the treatment of asthma: the story so far
1年前
已完结
-
Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies
1年前
已完结
-
Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies
1年前
已完结
-
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial
1年前
已完结
-
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
1年前
已完结
-
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study
1年前
已完结